NovoCure Limited header image

NovoCure Limited

NVCR

Equity

ISIN JE00BYSS4X48 / Valor 29570025

NASDAQ (2026-03-24)

USD 11.36-3.89%

NovoCure Limited
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

NovoCure Limited, founded in 2000 by Prof. Yoram Palti, is an international oncology company specializing in providing patients with a new cancer treatment known as Tumor Treating Fields. This innovative therapy is based on the discovery of the effects of TTFields on cancer cells, which disrupt cancer cell division when applied at specific frequencies. NovoCure's mission is to offer a completely different approach to cancer therapy, offering hope to patients seeking alternative treatment options.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-42.6%1Y

-80.1%3Y

-91.2%5Y

Performance

65.1%1Y

80.1%3Y

79.1%5Y

Volatility

1293 M

Market cap (USD)

1,097,153

Daily traded volume (Shares)

30.63 / 29.83

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Siemens Healthineers AG

Siemens Healthineers AG Valor: 40652181

Annual Return

-50%0%+50%

Risk level

110

0.14%EUR 36.71

Fresenius Medical Care AG

Fresenius Medical Care AG Valor: 520878

Annual Return

-50%0%+50%

Risk level

110

1.25%EUR 37.94

Evolent Health Inc

Evolent Health Inc Valor: 28153126

Annual Return

-50%0%+50%

Risk level

110

-9.64%USD 2.25

Vita 34 AG

Vita 34 AG Valor: 2333201

Annual Return

-50%0%+50%

Risk level

110

0.84%EUR 4.78

Maternus-Kliniken AG

Maternus-Kliniken AG Valor: 335800

Annual Return

-50%0%+50%

Risk level

110

-54.01%EUR 1.95

QuidelOrtho Corporation

QuidelOrtho Corporation Valor: 119356965

Annual Return

-50%0%+50%

Risk level

110

-2.30%USD 16.17

Novartis Inc

Novartis Inc Valor: 1200526

Annual Return

-50%0%+50%

Risk level

110

1.17%CHF 117.48

Savaria Corp

Savaria Corp Valor: 1385257

Annual Return

-50%0%+50%

Risk level

110

1.06%CAD 25.81

Johnson & Johnson

Johnson & Johnson Valor: 943981

Annual Return

-50%0%+50%

Risk level

110

-0.06%USD 235.27

Novo Nordisk A/S

Novo Nordisk A/S Valor: 461641

Annual Return

-50%0%+50%

Risk level

110

0.19%USD 36.89

SIX

FactSet

Clearbit

Logos provided by Clearbit